Cyclerion Therapeutics, Inc. Banner Image

Cyclerion Therapeutics, Inc. has reached its limit for free report views

Work for Cyclerion Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Cyclerion Therapeutics, Inc.

  • Ticker CYCN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cyclerion Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Lead programs include its vascular-targeted olinciguat in Phase 2 development for sickle cell disease and IW-6463, a pioneering CNS-penetrant sGC stimulator in clinical development forMore Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS) and Alzheimer's Disease with Vascular pathology (ADv)
Cyclerion Therapeutics, Inc.

Most Recent Annual Report

Cyclerion Therapeutics, Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Cyclerion Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports